AN ISHLT CONSENSUS STATEMENT ON STRATEGIES TO PREVENT AND MANAGE HEMOCOMPATIBILITY RELATED ADVERSE EVENTS IN PATIENTS WITH A DURABLE, CONTINUOUS-FLOW VENTRICULAR ASSIST DEVICE

被引:3
|
作者
Hollis, Ian B. [1 ,2 ]
Jennings, Douglas L. [3 ]
Krim, Selim [4 ]
Ton, Van-Khue [5 ]
Ducharme, Anique [6 ]
Cowger, Jennifer [7 ]
Looby, Mary [8 ]
Eulert-Green, J. J. [9 ]
Bansal, Neha [10 ]
Horn, Ed [11 ]
Byku, Mirnela [2 ]
Katz, Jason [12 ,13 ]
Michaud, C. J. [14 ]
Rajapreyar, Indranee [15 ]
Campbell, Patrick [16 ]
Vale, Cassandra [17 ]
Cosgrove, Richard [18 ]
Hernandez-Montfort, Jaime [19 ]
Otero, Jessica [20 ]
Ingemi, Amanda [21 ]
Raj, Shashi [22 ]
Weeks, Phillip [23 ]
Agarwal, Richa [24 ]
Martinez, Elena S. [25 ]
Tops, Laurens F. [26 ]
Ahmed, Mustafa M. [27 ]
Kiskaddon, Amy [28 ]
Kremer, Jamila [29 ]
Keebler, Mary [11 ]
Ratnagiri, Ravi K. [30 ]
机构
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ N Carolina, Med Ctr, Chapel Hill, NC USA
[3] Long Isl Univ, Coll Pharm, New York Presbyterian Columbia Irving Med Ctr, New York, NY USA
[4] John Ochsner Heart & Vasc Inst, New Orleans, LA USA
[5] Massachusetts Gen Hosp, Boston, MA USA
[6] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[7] Henry Ford Hosp, Detroit, MI USA
[8] Inova Fairfax Med Campus, Falls Church, VA USA
[9] Praxis Wloch, Berlin, Germany
[10] Mt Sinai Kravis Childrens Hosp, New York, NY USA
[11] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[12] NYU, Div Cardiol, Grossman Sch Med, New York, NY USA
[13] Bellevue Hosp, New York, NY USA
[14] Corewell Hlth, Grand Rapids, MI USA
[15] Tufts Med Ctr, Boston, MA USA
[16] Baptist Hlth Med Ctr, Little Rock, AR USA
[17] Prince Charles Hosp, Chermside, Qld, Australia
[18] Univ Arizona, Cornerstone Specialty Hosp, Coll Pharm, Tucson, AZ USA
[19] Baylor Scott & White Hlth Cent Texas & Greater Aus, Temple, TX USA
[20] AdventHlth Littleton Hosp, Littleton, CO USA
[21] Sentara Norfolk Gen Hosp, Norfolk, VA USA
[22] NH Hlth, Bangalore, India
[23] Mem Hermann Texas Med Ctr, Houston, TX USA
[24] Duke Univ, Med Ctr, Durham, NC USA
[25] Cardiovasc Surg Hosp Clin, Barcelona, Spain
[26] Leiden Univ, Med Ctr, Leiden, Netherlands
[27] Univ Florida Hlth, Gainesville, FL USA
[28] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[29] Univ Hosp Heidelberg, Heidelberg, Germany
[30] MGM Healthcare, Chennai, India
来源
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 08期
关键词
hemocompatibility; continuous-flow ventricular assist device; thrombosis; hemorrhage; vitamin K antagonists; antiplatelet medications; anticoagulation; PROTHROMBIN COMPLEX CONCENTRATE; MECHANICAL CIRCULATORY SUPPORT; HEPARIN-INDUCED THROMBOCYTOPENIA; PARTIAL THROMBOPLASTIN TIME; ANTI-FACTOR XA; REDUCES BLOOD REQUIREMENTS; HEALTH-CARE PROFESSIONALS; VON-WILLEBRAND SYNDROME; ACUTE ISCHEMIC-STROKE; HEARTMATE II PATIENTS;
D O I
10.1016/j.healun.2024.04.065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Life expectancy of patients with a durable, continuous-flow left ventricular assist device (CF-LVAD) continues to increase. Despite significant improvements in the delivery of care for patients with these devices, hemocompatability-related adverse events (HRAEs) are still a concern and contribute to significant morbility and mortality when they occur. As such, dissemination of current best evidence and practices is of critical importance. This ISHLT Consensus Statement is a summative assessment of the current literature on prevention and management of HRAEs through optimal management of oral anticoagulant and antiplatelet medications, parenteral anticoagulant medications, management of patients at high risk for HRAEs and those experiencing thrombotic or bleeding events, and device management outside of antithrombotic medications. This document is intended to assist clinicians caring for patients with a CF-LVAD provide the best care possible with respect to prevention and management of these events. J Heart Lung Transplant 2024;43:1199-1234 (c) 2024 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1199 / 1234
页数:36
相关论文
共 50 条
  • [21] Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences
    Stulak, John M.
    Davis, Mary E.
    Haglund, Nicholas
    Dunlay, Shannon
    Cowger, Jennifer
    Shah, Palak
    Pagani, Francis D.
    Aaronson, Keith D.
    Maltais, Simon
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (01): : 177 - 189
  • [22] Baseline QRS duration associates with cardiac recovery in patients with continuous-flow left ventricular assist device implantation
    Khan, Muhammad S.
    Kyriakopoulos, Christos P.
    Taleb, Iosif
    Dranow, Elizabeth
    Scott, Monte
    Ranjan, Ravi
    Yin, Michael
    Tseliou, Eleni
    Alharethi, Rami
    Caine, William
    Shaw, Robin M.
    Selzman, Craig H.
    Drakos, Stavros G.
    Dosdall, Derek J.
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 22
  • [23] Utility of the Psychosocial Assessment of Candidates for Transplantation in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation
    Halkar, Meghana
    Nowacki, Amy S.
    Kendall, Kay
    Efeovbokhan, Nephertiti
    Gorodeski, Eiran Z.
    Moazami, Nader
    Starling, Randall C.
    Young, James B.
    Lee, Sangjin
    Tang, W. H. Wilson
    PROGRESS IN TRANSPLANTATION, 2018, 28 (03) : 220 - 225
  • [24] Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II
    Wever-Pinzon, Omar
    Selzman, Craig H.
    Drakos, Stavros G.
    Saidi, Abdulfattah
    Stoddard, Gregory J.
    Gilbert, Edward M.
    Labedi, Mohamed
    Reid, Bruce B.
    Davis, Erin S.
    Kfoury, Abdallah G.
    Li, Dean Y.
    Stehlik, Josef
    Bader, Feras
    CIRCULATION-HEART FAILURE, 2013, 6 (03) : 517 - 526
  • [25] Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device
    Han, Jiho
    Takeda, Koji
    Takayama, Hiroo
    Kurlansky, Paul A.
    Mauro, Christine M.
    Colombo, Paolo C.
    Yuzefpolskaya, Melana
    Fukuhara, Shinichi
    Truby, Lauren K.
    Topkara, Veli K.
    Garan, Arthur R.
    Mancini, Donna M.
    Naka, Yoshifumi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (02): : 520 - U357
  • [26] Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
    Elasfar, Abdelfatah
    Jalali, Kafaf
    Hussein, Mohamed
    AlHarbi, Ibraheem
    Amoudi, Osama
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2018, 30 (03) : 268 - 270
  • [27] Increased platelet glycoprotein IIb/IIIa activation precedes continuous-flow left ventricular assist device pump thrombosis events
    Weiland, Matthew
    Schuitema, Jennifer
    Jovinge, Stefan
    Lee, Sangjin
    THROMBOSIS RESEARCH, 2021, 201 : 143 - 146
  • [28] Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial, thromboplastin time in patients supported with continuous-flow left ventricular assist devices
    Adatya, Sirtaz
    Sunny, Roy
    Fitzpatrick, Megan J.
    Colvin, Monica
    Thennapan, Thennapan
    John, Ranjit
    Zantek, Nicole Dodge
    Pritzker, Marc
    Eckman, Peter
    Uriel, Nir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1311 - 1320
  • [29] Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure
    Anand, Jatin
    Singh, Steve K.
    Hernandez, Ruben
    Parnis, Steven M.
    Civitello, Andrew B.
    Cohn, William E.
    Mallidi, Hari R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 149 (01): : 267 - +
  • [30] Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death
    Levin, Allison P.
    Saeed, Omar
    Willey, Joshua Z.
    Levin, Charles J.
    Fried, Justin A.
    Patel, Snehal R.
    Sims, Daniel B.
    Nguyen, Jenni D.
    Shin, Julia J.
    Topkara, Veli K.
    Colombo, Paolo C.
    Goldstein, Daniel J.
    Naka, Yoshifumi
    Takayama, Hiroo
    Uriel, Nir
    Jorde, Ulrich P.
    CIRCULATION-HEART FAILURE, 2016, 9 (05)